Press Releases

GlobeNewswire, Inc.

NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study NEO-CYT is a Phase 1b...

GlobeNewswire, Inc.

Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Informatics Market Size, Trends and Insights By Type (Electronic Health Records, Clinical Trial Management System,...

GlobeNewswire, Inc.

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- TMF Group, a leading provider of compliance and administrative services, today launches the 13th edition of the Global Business Complexity Index (GBCI), which shows that operating across borders is becoming...

GlobeNewswire, Inc.

Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Wearable Health Silicone Elastomers Market Size, Trends and Insights By Type (High Consistency Rubber, Liquid Silicone Rubber), By...

GlobeNewswire, Inc.

Austin, TX, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Flexible Endoscope Market Size, Trends and Insights By Product (Bronchoscopes, Laparoscopes, Otoscopes, Laryngoscopes, Cystoscopes,...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC...

EIN Presswire

IMARC Group's Latest Research Reveals a CAGR of 3.78% from 2026–2034, with Pearl Millet and Infant Food Segments Leading Expansion SHERIDAN, WY, UNITED STATES, May 11, 2026 /⁨EINPresswire.com⁩/ -- The global millet market size reached USD 14.0...

GlobeNewswire, Inc.

Origin, price and seasonality: the three-tier hierarchy emerging from the survey by the Research Department.

GlobeNewswire, Inc.

- Duchenne (SGT-003): First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s Pediatric Investigation Plan from the European Medicines Agency and Orphan drug designation from the European...

EIN Presswire

FDA premarket rejections have surged since the February 2026 cybersecurity guidance.

EIN Presswire

LogicalDOC Srl is proud to be a winner of the Top Performer award from SourceForge, the world’s largest software reviews and comparison website.

GlobeNewswire, Inc.

Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis(3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%) EBITDA(1) of € 283.6 million, +5.0%, margin on net...

GlobeNewswire, Inc.

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session Company to host investor conference call and webcast during EHA 2026 on Saturday, June 13, at 9:00 a.m. ET (3:00...

EIN Presswire

Russo’s New York Pizzeria announces nationwide franchise opportunities for qualified investors seeking to join a proven Italian dining brand.

GlobeNewswire, Inc.

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas Institute of the University of Verona The study is the first Alpha DaRT pancreatic cancer protocol worldwide...

GlobeNewswire, Inc.

Brescia, Italy, May 07, 2026 (GLOBE NEWSWIRE) -- VCD Medical, an Italy-based startup developing a novel, minimally invasive vein closure device, has hired Denna Babul, RN, as its General Manager.

GlobeNewswire, Inc.

- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development program designed to support registration and global regulatory authorizations for SGT-003 - - Solid...

GlobeNewswire, Inc.

The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4.1 billion USD, representing...

GlobeNewswire, Inc.

Debra Hussain brings over 25 years of deep expertise in implementing commercial excellence and driving the launch of products and portfolio growth spanning multiple therapeutic areas Chiesi USA continues to invest in its US CARE business unit,...

GlobeNewswire, Inc.

- Phase 3 CALIBRATE primary results were presented in an oral presentation at the 2026 ECE, demonstrating the rapid and durable benefit of encaleret across key clinical parameters in ADH1 - All pre-specified primary and key secondary efficacy...